4//SEC Filing
Miles Darrin 4
Accession 0001439222-21-000008
CIK 0001439222other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:24 PM ET
Size
7.8 KB
Accession
0001439222-21-000008
Insider Transaction Report
Form 4
Miles Darrin
Chief Commercial Officer
Transactions
- Award
Restricted stock units
2021-02-10+11,000→ 11,000 total→ Common stock (11,000 underlying) - Award
Common stock
2021-02-10+44,000→ 44,000 totalExercise: $56.68Exp: 2031-02-10→ Common stock (44,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.
- [F3]This option was granted on February 10, 2021. The shares underlying this option vest as to 25% of the underlying shares on February 10, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001840076
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 4:24 PM ET
- Size
- 7.8 KB